Cell Growth & Differentiation, Vol 5, Issue 4 385-394, Copyright © 1994 by American Association of Cancer Research

ARTICLES

Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways

C Jhappan, H Takayama, RB Dickson and G Merlino
Laboratory of Molecular Biology, National Cancer Institute, NIH, Bethesda, Maryland 20892.

The epidermal growth factor receptor (EGFR), which mediates the mitogenic activity of transforming growth factor alpha (TGF-alpha), has been shown to activate Ras in cultured cells through well-defined intermediary proteins. To examine the in vivo relationship between EGFR and Ras, chemical carcinogenesis of TGF-alpha transgenic mouse skin was chosen as an experimental model. Transgenic mice overexpressing TGF-alpha in a wide variety of epithelial tissues by virtue of a metallothionein promoter demonstrate a multitude of premalignant and neoplastic lesions but not spontaneous skin tumors. Transgenic skin was initiated with a single dose of 7,12-dimethylbenz[a]anthracene (DMBA), shown previously to induce, in concert with a tumor promoter, murine papillomas that consistently contain specific H-ras mutations. Virtually all DMBA-treated TGF-alpha transgenic mice, but not treated control animals, developed hyperplasias, papillomas, sebaceous adenomas, and more infrequently, sebaceous and squamous cell carcinomas. Therefore, TGF-alpha functions as an autonomous tumor promoter in DMBA-initiated transgenic skin. Skin tumors could be separated into two mutually exclusive genetic classes. In tumors harboring mutant H-ras, TGF-alpha transgene expression was relatively low and essentially unchanged relative to untreated skin; however, only 42% of skin tumors contained mutations in H-ras. Conversely, in most tumors with wild-type H-ras, transgenic TGF-alpha transcripts were enhanced 10- to 20-fold. These results suggest that strong constitutive EGFR stimulation, through TGF-alpha transgene overexpression, can substitute functionally for mutational activation of H-ras in skin tumorigenesis. Moreover, because H-ras mutational activation could not induce skin tumors without TGF-alpha transgene activity, simultaneous stimulation of an EGFR-mediated H-Ras-independent pathway appears to be required for tumor development as well.

This article has been cited by other articles:

				M. R. Schneider, S. Werner, R. Paus, and E. Wolf Beyond Wavy Hairs: The Epidermal Growth Factor Receptor and Its Ligands in Skin Biology and Pathology Am. J. Pathol., July 1, 2008; 173(1): 14 - 24. [Abstract] [Full Text] [PDF]

				C. T. Charalambous, A. Hannigan, P. Tsimbouri, G. M. McPhee, and J. B. Wilson Latent membrane protein 1-induced EGFR signalling is negatively regulated by TGF{alpha} prior to neoplasia Carcinogenesis, August 1, 2007; 28(8): 1839 - 1848. [Abstract] [Full Text] [PDF]

				K. S. Chan, S. Carbajal, K. Kiguchi, J. Clifford, S. Sano, and J. DiGiovanni Epidermal Growth Factor Receptor-Mediated Activation of Stat3 during Multistage Skin Carcinogenesis Cancer Res., April 1, 2004; 64(7): 2382 - 2389. [Abstract] [Full Text] [PDF]

				J. A. Curran, F. S. Laverty, D. Campbell, J. Macdiarmid, and J. B. Wilson Epstein-Barr Virus Encoded Latent Membrane Protein-1 Induces Epithelial Cell Proliferation and Sensitizes Transgenic Mice to Chemical Carcinogenesis Cancer Res., September 1, 2001; 61(18): 6730 - 6738. [Abstract] [Full Text] [PDF]

				C. D. Woodworth, D. Gaiotti, E. Michael, L. Hansen, and M. Nees Targeted Disruption of the Epidermal Growth Factor Receptor Inhibits Development of Papillomas and Carcinomas from Human Papillomavirus-immortalized Keratinocytes Cancer Res., August 1, 2000; 60(16): 4397 - 4402. [Abstract] [Full Text]

				S.-J. C. Wei, R. L. Chang, K. A. Merkler, M. Gwynne, X. X. Cui, B. Murthy, M.-T. Huang, J.-G. Xie, Y.-P. Lu, Y.-R. Lou, et al. Dose-dependent mutation profile in the c-Ha-ras proto-oncogene of skin tumors in mice initiated with benzo[a]pyrene Carcinogenesis, September 1, 1999; 20(9): 1689 - 1696. [Abstract] [Full Text] [PDF]

				C. Go, P. Li, and X.-J. Wang Blocking Transforming Growth Factor {beta} Signaling in Transgenic Epidermis Accelerates Chemical Carcinogenesis: A Mechanism Associated with Increased Angiogenesis Cancer Res., June 1, 1999; 59(12): 2861 - 2868. [Abstract] [Full Text] [PDF]

				C. M. Bral and K. S. Ramos Identification of Benzo[a]pyrene-Inducible Cis-Acting Elements Within c-Ha-ras Transcriptional Regulatory Sequences Mol. Pharmacol., December 1, 1997; 52(6): 974 - 982. [Abstract] [Full Text]